Last reviewed · How we verify
Calcium and Magnesium
Calcium and Magnesium is a Mineral supplement Small molecule drug developed by Sanofi. It is currently FDA-approved for Calcium and magnesium deficiency, Osteoporosis prevention and treatment, Muscle cramps and spasms. Also known as: Ca, Mg, Calcium, Magnesium.
Calcium and magnesium are essential mineral supplements that replenish electrolyte levels and support cellular function, muscle contraction, and nerve transmission.
Calcium and Magnesium are not directly related to the conditions studied in ClinicalTrials.gov, which include SARS-CoV-2 Virus Infection, Colorectal Cancer, SLE, Lupus, and Systemic Lupus Erythematosus. However, Calcium and Magnesium are essential minerals that play crucial roles in various bodily functions, including muscle and nerve function, and are often studied in the context of overall health and nutrition.
At a glance
| Generic name | Calcium and Magnesium |
|---|---|
| Also known as | Ca, Mg, Calcium, Magnesium |
| Sponsor | Sanofi |
| Drug class | Mineral supplement |
| Modality | Small molecule |
| Therapeutic area | Nutritional/Metabolic |
| Phase | FDA-approved |
Mechanism of action
Calcium is critical for bone mineralization, muscle contraction, and cellular signaling, while magnesium serves as a cofactor for hundreds of enzymatic reactions and is essential for ATP production and neuromuscular function. Together, these minerals help maintain electrolyte balance, support cardiovascular function, and prevent deficiency-related complications.
Approved indications
- Calcium and magnesium deficiency
- Osteoporosis prevention and treatment
- Muscle cramps and spasms
- Cardiovascular support
Common side effects
- Gastrointestinal upset (nausea, constipation, diarrhea)
- Hypercalcemia (with excessive intake)
- Hypermagnesemia (with excessive intake)
Key clinical trials
- Effect of Postbiotics on Microbiota and Systemic Immunomodulation of Pembrolizumab as First-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (RM HNSCC) (PHASE2)
- PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition (PHASE2)
- Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis (PHASE3)
- Theravex Oral and Theravex Tissue Care Plus in the Healing Process of Mucogingival Surgery (NA)
- Opioid-Free Pain Protocol After Shoulder Arthroplasty (PHASE4)
- Quality of Life in Diarrhea-predominant Irritable Bowel Syndrome Taking GABA (NA)
- Knee Osteoarthritis and Thermal Spa Treatment (NA)
- Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Calcium and Magnesium CI brief — competitive landscape report
- Calcium and Magnesium updates RSS · CI watch RSS
- Sanofi portfolio CI
Frequently asked questions about Calcium and Magnesium
What is Calcium and Magnesium?
How does Calcium and Magnesium work?
What is Calcium and Magnesium used for?
Who makes Calcium and Magnesium?
Is Calcium and Magnesium also known as anything else?
What drug class is Calcium and Magnesium in?
What development phase is Calcium and Magnesium in?
What are the side effects of Calcium and Magnesium?
Related
- Drug class: All Mineral supplement drugs
- Manufacturer: Sanofi — full pipeline
- Therapeutic area: All drugs in Nutritional/Metabolic
- Indication: Drugs for Calcium and magnesium deficiency
- Indication: Drugs for Osteoporosis prevention and treatment
- Indication: Drugs for Muscle cramps and spasms
- Also known as: Ca, Mg, Calcium, Magnesium
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing